Azenta Inc (AZTA) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Total Revenue Chart for Azenta Inc

Azenta Inc (AZTA) revenue for FY2025 was USD 593.8M, a 3.6% change from FY2024. Azenta Inc's revenue grew from USD 24.0M in 1994 to USD 593.8M in 2025 (2374.3% over 31 years). Earnings per share grew from USD 1.64 in 2018 to USD -0.22 in 2023 (-113.1%). Revenue compound annual growth rate: 5-year CAGR of 8.9%, 10-year CAGR of 0.7%, 20-year CAGR of 1.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.60B
Implied Share Price
$36.50
Enterprise Value
$1.05B
Revenue (TTM)
$613.81M
EBITDA
$33.01M
Profit Margin
-20.02%
Trailing P/E
—
Forward P/E
29.07
Price/Book (MRQ)
0.87
Price/Sales (TTM)
2.61
EV/EBITDA
31.86
EV/Revenue
1.71
Dividend Yield
—
Book Value
$34.51
Free Cash Flow (FY2025)
$38.32M
Free Cash Flow Yield
2.40%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.